Day: November 13, 2025
REGULATED INFORMATIONBrussels, 13 November 2025, 5:55 PMRESULTS ON Q3 2025HIGHLIGHTS
NEXTENSA ACHIEVES SOLID RESULTS IN Q3
In the third quarter of 2025 Nextensa maintained its strong momentum and achieved a clear increase in profitability. Net profit increased significantly, driven by a higher contribution of development activities, lower financing costs and a further strengthening of the balance sheet.
Three significant transactions were completed in Q3 2025:Sale of Retail Estates. On August 28,2025, Nextensa has sold its entire 8.99% stake in the Belgian REIT Retail Estates, generating proceeds of €89.6 M.
Sale of Monteco in Belgium on September 17, 2025: 100% of the shares of Monteco BV were sold jointly with ION for a valuation of €28 M.
Sale of retail property in Ingeldorf, Luxembourg, on September 29, 2025, to the State of...
Bonduelle – Combined General Meeting of December 4, 2025: Statement of availibilty of documents
Written by Customer Service on . Posted in Public Companies.
BONDUELLE
Head office: “La Woestyne” – 59173 Renescure – FranceBonduelle a French S.C.A (Partnership limited by Shares) with a capital of 57 102 699,50 eurosRegistered under number : 447 250 044 ( Dunkerque Commercial and Companies Register)
Villeneuve d’Ascq, November 13, 2025
Press release
COMBINED GENERAL MEETING OF DECEMBER 4, 2025
Statement of availability of documents
Shareholders are invited to attend the Combined General Meeting to be held on December 4, 2025 at 5 p.m. at the Company’s administrative headquarters, Rue Nicolas Appert, 59650 Villeneuve d’Ascq, France.
The prior notice including the agenda and draft resolutions was published in the Bulletin des Annonces Légales Obligatoires (hereinafter “BALO”) no. 128 of October 24, 2025, and the notice of meeting will be published...
JCDecaux strengthens leadership in São Paulo Metro with the renewal and extension of contract for Lines 1-Blue, 2-Green, and 3-Red, and the inclusion of Line 15-Silver through 2036
Written by Customer Service on . Posted in Public Companies.
JCDecaux strengthens leadership in São Paulo Metro with the renewal and extension of contract for Lines 1-Blue, 2-Green, and 3-Red, and the inclusion of Line 15-Silver through 2036
Paris, November 13th, 2025 – JCDecaux SE (Euronext Paris: DEC), the number one outdoor advertising company worldwide, announces that its subsidiary JCDecaux Brazil has renewed and extended its advertising concession contract for the 1-Blue, 2-Green, and 3-Red lines of São Paulo Metro, along with the inclusion of Line 15-Silver, through 2036.
The agreement, initially valid until 2030, has been extended to February 2036, adding six more years of operation and media management in São Paulo’s metro system. The contract renewal, as well as the expansion to Line 15-Silver, will take effect in February 2026.
JCDecaux will be present in 63 metro stations...
Elis: Share capital increase reserved for employees “Elis for All 2025”
Written by Customer Service on . Posted in Public Companies.
Share capital increase reserved for employees “Elis for All 2025”
Saint-Cloud, 13 November 2025
The subscription period for the share capital increase reserved for Elis employees ended on 2 October 2025. 5.8% of employees in 20 countries chose to participate, either directly or via the Elis Group employee shareholding fund, in this operation, for a total subscription of nearly 15 million euros.
Implemented by the Elis Supervisory Board on December 17, 2024 and by the Management Board on July 31, 2025, on the basis of a delegation of authority from the General Meeting of May 23, 2024 (France) and May 22, 2025 (foreign countries), the share capital increase allowed the Group’s employees to invest in Elis shares at a unit price of 16.86 euros, corresponding to the average opening price of the share from August 18 to September 12 2025,...
Ramsay Sante : Interim results at the end of September 2025
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
PRESS RELEASE Paris, 13th November 2025
Interim results at the end of September 2025
Revenue growth of 2.6% and Group EBITDA up 6.5% despite reduction in public funding; resilient operating performance
Activity growth and cost control compensate constrained fundingUnaudited group revenue for the quarter ending 30 September 2025 increased by 2.6% to 1.21bn€ supported by activity volume growth, price indexation in Sweden and favourable foreign exchange movements. Revenue growth of 1.9% on a like-for-like basis.
Acute hospitals admission volume growth in France and Sweden despite 1 less business day this quarter compared to the same period last year, reflecting sustained patient need for healthcare and the capacity of the group’s facilities to provide more quality care services in a competitive landscape.
Unaudited...
Iceland Seafood International hf: Q1 2025 Uppgjör og fjárfestakynning
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Áframhaldandi viðsnúningur, hagnaður fyrir skatta 590 milljónir ISK af reglulegri starfsemi Hagnaður fyrir skatta af reglulegri starfsemi nam 590 milljónum ISK (€4.1m) samanborið við 360 milljónir ISK (€2.5m) 9M 2024 sem er aukning um 230 milljónir ISK (€1.6m) Rekstrartekjur 9M 2025 námu 50,1 milljörðum ISK (€347.6m), sem er aukning um 11% eða 4,8 milljarða ISK (€33.6m) frá sama tímabili 2024 Framlegð fyrir 9M 2025 er 4,9 milljarðar ISK (€34.2m) samanborið við 4,1 milljarð ISK (€28.7m) á sama tímabili 2024 EBITDA fyrir 9M 2025 hækkaði um 55% í 2,0 milljarða ISK (€14.0m) frá 1,3 milljörðum ISK (€9.0m) 9M 2024 EBITDA síðustu 12 mánaða hækkaði um 0,9 milljarð ISK, í 3 milljarða ISK (€21.1m) frá 2,1 milljarði ISK (€14.8m) á Q3 2024 Hagnaður fyrstu níu mánuði eftir skatta er 360 milljónir ISK (€2.5m) samanborið við 216 milljóna ISK (€1.5m) tap fyrir...
Kura Oncology and Kyowa Kirin Announce FDA Approval of KOMZIFTI™ (ziftomenib), the First and Only Once-Daily Targeted Therapy for Adults with Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia
Written by Customer Service on . Posted in Public Companies.
– NPM1 mutations, one of the most common genetic drivers of AML, are now actionable for patients –
– Acute unmet need in R/R NPM1-mutated AML defined by historically poor outcomes and low survival rates at relapse –
– FDA grants full approval of KOMZIFTI ahead of PDUFA target action date –
– Approval is based on the KOMET-001 trial, in which KOMZIFTI demonstrated deep responses, a potentially best-in-class safety profile, once-daily administration, and ease of co-administration with common supportive medications in adult patients with R/R NPM1-mutated AML –
– KOMZIFTI approval granted with no Boxed Warning related to QTc prolongation or Torsades de Pointes –
– Kura Oncology will host a conference call on November 13, 2025, at 12:30 pm ET / 9:30 am PT –
SAN DIEGO and TOYKO, Nov. 13, 2025 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq:...
Treasury Bill Auction Announcement – RIKV 26 0318 – RIKV 26 0520
Written by Customer Service on . Posted in Public Companies.
Series
RIKV 26 0318
RIKV 26 0520ISIN
IS0000038016
IS0000038487Maturity Date
03/18/2026
05/20/2026Auction Date
11/17/2025
11/17/2025Settlement Date
11/19/2025
11/19/2025On the Auction Date, between 10:30 am and 11:00 am, the Government Debt Management will auction Treasury bills in the Series, with the ISIN numbers and with the Maturity Dates according to the table above. Payments for the Treasury bills must be received by the Central Bank before 14:00 on the Settlement Date and the Bills will be delivered in electronic form on the same day.
Further reference is made to the General Terms of Icelandic Treasury bills and General Terms of Auction for Treasury bills on the Government Debt Management website.
For additional information please contact Oddgeir Gunnarsson, Government Debt Management, at +354 569 9635.
Cenovus announces closing of MEG Energy acquisition
Written by Customer Service on . Posted in Mergers And Acquisitions.
CALGARY, Alberta, Nov. 13, 2025 (GLOBE NEWSWIRE) — Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) is pleased to announce that its acquisition of MEG Energy Corp. (TSX: MEG) (MEG) was completed today. This acquisition strengthens Cenovus’s portfolio of long-life, low-cost oil sands assets, adding top-tier operations that are directly adjacent to the company’s Christina Lake asset.
Total consideration paid by Cenovus included:$752 million of cash paid for 25.0 million MEG shares acquired through open market transactions.
$3.44 billion of cash paid to MEG shareholders, other than Cenovus, under the terms of the agreement.
143.9 million Cenovus common shares issued to MEG shareholders, other than Cenovus, under the terms of the agreement.
Approximately $800 million of estimated net debt assumed, on closing.“The addition of MEG assets...
Inventiva announces trading resumption of its ordinary shares on Euronext Paris
Written by Customer Service on . Posted in Public Companies.
Daix (France), New York City (New York, United States), November 13, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company“), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH“), announced the trading resumption of its ordinary shares on the regulated market of Euronext in Paris as from 4:30 p.m. (CET).
Trading of the ordinary shares of the Company was halted, at the Company’s request, on November 13, 2025, from 9:00 a.m. (CET), in the context of the previously announced public offering by the Company in the United States only of new American Depositary Shares, each representing one new ordinary share of the Company with a nominal value of €0.01 (the “Offering“),...
